Rights and permissions
About this article
Cite this article
Denosumab superior to alendronic acid for BMD gains. Inpharma Wkly. 1640, 10 (2008). https://doi.org/10.2165/00128413-200816400-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816400-00016